1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aclaris Therapeutics Inc (ACRS)

  7. Aclaris Therapeutics Inc (ACRS) Financials

ACRS

Aclaris Therapeutics Inc
8.01
-0.14 (-1.72%)
Upgrade to Real-Time

Aclaris Therapeutics Inc. (ACRS) Fundamentals
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The contract research segment earns revenue from the provision of laboratory services. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777.
SHARE INFORMATION
Market CapUS$ 526,874,416
Shares Outstanding66,692,964
Float64,285,278
Percent Float96.39%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 29,752,000
Latest Fiscal EPSUS$ -1.33
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions306
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months4,442,270
Institutional Holdings Percent127.3%
Institutional Sold Previous 3 Months4,229,723
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months1,037,250
Insider Holdings Percent3.8
Insider Sold Previous 3 Months99,517
Insider Shares Owned2,507,771
TRADING INFO
52 Week HighUS$ 18.96
52 Week LowUS$ 5.77
52 Week High ChangeUS$ -54.20
21 Day Moving AverageUS$ 9.6262
21 Day Extended Moving AverageUS$ 9.5146
50 Day Moving AverageUS$ 13.0346
50 Day Extended Moving AverageUS$ 11.8154
200 Day Moving AverageUS$ 15.0906
200 Day Extended Moving AverageUS$ 14.3557
10 Day Average Volume930,515
20 Day Average Volume1,838,267
30 Day Average Volume1,534,601
50 Day Average Volume1,178,162
Alpha0.030792
Beta0.6118
Standard Deviation0.370200
R20.007920
7 Day Price ChangeUS$ -0.09
7 Day Percent Change-1.13%
21 Day Price ChangeUS$ -4.34
21 Day Percent Change-35.46%
30 Day Price ChangeUS$ -4.79
30 Day Percent Change-37.75%
Month to Date Price ChangeUS$ -4.56
Month to Date Percent Change-36.6%
Quarter to Date Price ChangeUS$ -7.85
Quarter to Date Percent Change-49.84%
180 Day Price ChangeUS$ -5.95
180 Day Percent Change-42.96%
200 Day Price ChangeUS$ -9.22
200 Day Percent Change-53.86%
Year to Date Price ChangeUS$ -7.85
Year to Date Percent Change-49.84%

Aclaris Therapeutics Inc. (ACRS) Key Ratios

PROFITABILITY
EBIT Margin-356.9%
EBITDA Margin-353.5%
Pre-Tax Profit Margin-1,321.0%
Profit Margin Count0.0%
Gross Margin59.5%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 29,752,000
Revenue Per ShareUS$ 0.4461
Revenue (3 Years)US$ 28.78
Revenue (5 Years)US$ 42.78
FINANCIAL STRENGTH
Price to Tangible Book2.90
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio10.60
Leverage Ratio1.20
Quick Ratio9.90
Long Term Debt To Capital0.04
VALUATION MEASURES
PE Ratio-9.10
Enterprise ValueUS$ 332,663,023
Price to Sales17.7089
Price to Free Cash-8.10
PE High Last 5 Years-2.00
Price To Book2.80
Price To Cash Flow0.00
PE Low Last 5 Years-5.70
Price to Tangible Book2.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover55.00
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-35.36
Return on Equity-45.29
Return on Capital-37.49

Aclaris Therapeutics Inc. (ACRS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEODouglas J. Manion
Emplyoees105
Last AuditUQ
CIK0001557746
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address640 Lee Road
Suite 200
Wayne, PA 19087
Websitehttps://www.aclaristx.com
Facsimile+1 484 320-2344
Telephone+1 484 324-7933
Emailmtung@aclaristx.com
Your Recent History
NASDAQ
ACRS
Aclaris Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 05:28:27